In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0569, Lutfu Askin, Kader Eliz Uzel, Okan Tanriverdi and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider serum irisin pathogenesis and clinical research in cardiovascular diseases.
The authors summarize studies on the role of serum irisin levels in the process of atherosclerosis and other cardiovascular events in cardiovascular diseases. Irisin is a recently discovered molecule produced by muscles. It has been shown to be associated with different metabolic markers. Current studies suggest that irisin is a promising therapeutic agent in diseases such as DM, metabolic syndrome, and CVDs.